GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » Return-on-Tangible-Asset

Itonis (Itonis) Return-on-Tangible-Asset : -1,017.07% (As of Feb. 2008)


View and export this data going back to 2007. Start your Free Trial

What is Itonis Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Itonis's annualized Net Income for the quarter that ended in Feb. 2008 was $-1.67 Mil. Itonis's average total tangible assets for the quarter that ended in Feb. 2008 was $0.16 Mil. Therefore, Itonis's annualized Return-on-Tangible-Asset for the quarter that ended in Feb. 2008 was -1,017.07%.

The historical rank and industry rank for Itonis's Return-on-Tangible-Asset or its related term are showing as below:

ITNS's Return-on-Tangible-Asset is not ranked *
in the Medical Distribution industry.
Industry Median: 2.52
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Itonis Return-on-Tangible-Asset Historical Data

The historical data trend for Itonis's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis Return-on-Tangible-Asset Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
Return-on-Tangible-Asset
-576.80 -1,680.29 -2,662.86

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only -382.43 -438.27 -384.36 -2,171.95 -1,017.07

Competitive Comparison of Itonis's Return-on-Tangible-Asset

For the Medical Distribution subindustry, Itonis's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Itonis's Return-on-Tangible-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Itonis's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Itonis's Return-on-Tangible-Asset falls into.



Itonis Return-on-Tangible-Asset Calculation

Itonis's annualized Return-on-Tangible-Asset for the fiscal year that ended in Nov. 2007 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Nov. 2007 )  (A: Nov. 2006 )(A: Nov. 2007 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Nov. 2007 )  (A: Nov. 2006 )(A: Nov. 2007 )
=-1.398/( (0.08+0.025)/ 2 )
=-1.398/0.0525
=-2,662.86 %

Itonis's annualized Return-on-Tangible-Asset for the quarter that ended in Feb. 2008 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Feb. 2008 )  (Q: Nov. 2007 )(Q: Feb. 2008 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Feb. 2008 )  (Q: Nov. 2007 )(Q: Feb. 2008 )
=-1.668/( (0.025+0.303)/ 2 )
=-1.668/0.164
=-1,017.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Feb. 2008) net income data.


Itonis  (OTCPK:ITNS) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Itonis Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Itonis's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Itonis (Itonis) Business Description

Traded in Other Exchanges
N/A
Address
22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines